Imuran
Phase 3Small molecule
Imuran is one of 45 small molecule programs targeting Infertility. It is currently in Phase 3.
1
Indications
2
Total Trials
2
Active Trials
44
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
49 competitors in Infertility
#DrugCompanyPhaseTrials
1Femara
NovartisApproved
Estrace
Novo NordiskApproved
Lupron
Sun Pharmaceutical Industries, Inc.Approved
Danocrine
SanofiApproved
Nolvadex
AstraZenecaApproved
Bayer Aspirin
BayerApproved
Glucophage
EMD SeronoApproved
Prometrium
FerringApproved
Imuran
LLegacy Health System
Approved
Injectafer
AAmerican Regent, Inc.
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Liver Transplant1 trial
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Enrolling by invitation·—·Phase 4·NCT02081755·336 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Imuran. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- JJohns Hopkins University